Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT

Completed

Conditions studied: Liver Cancer

In brief

This study is being done to investigate the influence of giving radiation to the liver on tumors involving the liver. Investigator is specifically looking at this effect on the blood vessels within the tumor. This effect will be measured by studying substances in the blood that the tumors produce and that cause blood vessels to grow. The effects seen on these substances may help design other treatments to improve the results of the radiation used to treat these tumors.

Key facts

Study ID

NCT00994370

Run by

Rutgers, The State University of New Jersey

People needed

36

Starts

2009-04-01

Expected to finish

2013-01-01

Last updated by the study team

2014-03-20

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients between the ages of 18-85 who have been referred for SIRT as standard of care treatment for hepatocellular carcinoma or colorectal metastases to the liver and qualify for treatment with SIRT
• Life expectancy of at least 3 months

You may not qualify if…

• Patients are excluded from participation in this study if they are not undergoing the SIRT procedure

Where it is running

• Robert Wood Johnson University Hospital — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.